AAS

AAS Biotech (Advanced Applied Science Biotech) is a biotechnology company specializing in the development and application of active microbial cells for human, animal, and agricultural health. Founded in 2016 and headquartered in Vietnam, the company utilizes its proprietary Bio-Lock Technology to stabilize and protect beneficial bacteria, ensuring high potency and efficacy in various environments. AAS Biotech's portfolio includes advanced seed treatments like SEED CT-1, which enhances crop resilience and nutrient absorption, as well as human health solutions focused on the microbiome. The company leverages advanced analytical techniques such as Next-Generation Sequencing (NGS) and Alpha Diversity Studies to optimize its microbial formulations. Through strategic partnerships, such as its distribution agreement with Organotechnie for peptone products, AAS Biotech aims to scale its biotechnological innovations globally.